Solution characterization of [methyl-13C]methionine HIV-1 reverse transcriptase by NMR spectroscopy

Antiviral Research

Volumn 84, Issue 3, 2009, Pages 205-214

  Zheng, Xunhai ^a   Mueller, Geoffrey A ^a   DeRose, Eugene F ^a   London, Robert E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Methyl 13C methionine labeled; HIV 1 reverse transcriptase; NMR spectroscopy; Solution behavior

Indexed keywords

METHIONINE METHYL C 13; NEVIRAPINE; RADIOPHARMACEUTICAL AGENT; RNA DIRECTED DNA POLYMERASE; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME CONFORMATION; ENZYME SUBUNIT; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOTOPE LABELING; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS;

AMINO ACID MOTIFS; CARBON ISOTOPES; CATALYTIC DOMAIN; HIV REVERSE TRANSCRIPTASE; HIV-1; METHIONINE; MOLECULAR CONFORMATION; MUTAGENESIS, SITE-DIRECTED; NEVIRAPINE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; REVERSE TRANSCRIPTASE INHIBITORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70449726535     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.07.021     Document Type: Article

References (46)

1. Autran B., Carcelain G., Li T.S., Blanc C., Mathez D., Tubiana R., Katlama C., Debre P., and Leibowitch J. Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112-116
2. Bauman J.D., Das K., Ho W.C., Baweja M., Himmel D.M., Clark A.D., Oren D.A., Boyer P.L., Hughes S.H., Shatkin A.J., and Arnold E. Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Nucleic Acids Res. 36 (2008) 5083-5092
3. Bose-Basu B., DeRose E.F., Kirby T.W., Mueller G.A., Beard W.A., Wilson S.H., and London R.E. Dynamic characterization of a DNA repair enzyme: NMR studies of [methyl-C-13]methionine-labeled DNA polymerase beta. Biochemistry 43 (2004) 8911-8922
4. Chamberlain P.P., Ren J., Nichols C.E., Douglas L., Lennerstrand J., Larder B.A., Stuart D.I., and Stammers D.K. Crystal structures of zidovudine- or lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215. J. Virol. 76 (2002) 10015-10019
5. Das K., Sarafianos S.G., Clark A.D., Boyer P.L., Hughes S.H., and Arnold E. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097. J. Mol. Biol. 365 (2007) 77-89
6. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
7. Dellavecchia M.J., Merrittt W.K., Peng Y., Kirby T.W., Derose E.F., Mueller G.A., Van Houten B., and London R.E. NMR analysis of [methyl-C-13]methionine UvrB from Bacillus caldotenax reveals UvrB-domain 4 heterodimer formation in solution. J. Mol. Biol. 373 (2007) 282-295
8. Ding J., Das K., Hsiou Y., Sarafianos S.G., Clark Jr. A.D., Jacobo-Molina A., Tantillo C., Hughes S.H., and Arnold E. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. J. Mol. Biol. 284 (1998) 1095-1111
9. Esnouf R., Ren J., Ross C., Jones Y., Stammers D., and Stuart D. Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nat. Struct. Biol. 2 (1995) 303-308
10. Ghosh M., Jacques P.S., Rodgers D.W., Ottman M., Darlix J.L., and Le Grice S.F. Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization. Biochemistry 35 (1996) 8553-8562
11. Gregoret L.M., Rader S.D., Fletterick R.J., and Cohen F.E. Hydrogen bonds involving sulfur atoms in proteins. Proteins 9 (1991) 99-107
12. Gutierrez-Rivas M., and Menendez-Arias L. A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis. Nucleic Acids Res. 29 (2001) 4963-4972
13. Hinck A.P., Eberhardt E.S., and Markley J.L. NMR strategy for determining Xaa-Pro peptide bond configurations in proteins: mutants of staphylococcal nuclease with altered configuration at proline-117. Biochemistry 32 (1993) 11810-11818
14. Hou E.W., Prasad R., Beard W.A., and Wilson S.H. High-level expression and purification of untagged and histidine-tagged HIV-1 reverse transcriptase. Protein Expr. Purif. 34 (2004) 75-86
15. Hsiou Y., Ding J., Das K., Clark A.D., Hughes S.H., and Arnold E. Structure of unliganded HIV-1 reverse transcriptase at 2.7 angstrom resolution: Implications of conformational changes for polymerization and inhibition mechanisms. Structure 4 (1996) 853-860
16. Ivetac A., and Mccammon J.A. Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations. J. Mol. Biol. 388 (2009) 644-658
17. Johnson B.A., and Blevins R.A. NMR view-a computer-program for the visualization and analysis of NMR Data. J. Biomol. NMR 4 (1994) 603-614
18. Kensch O., Restle T., Wohrl B.M., Goody R.S., and Steinhoff H.J. Temperature-dependent equilibrium between the open and closed conformation of the p66 subunit of HIV-1 reverse transcriptase revealed by site-directed spin labelling. J. Mol. Biol. 301 (2000) 1029-1039
19. Klingler T.M., and Brutlag D.L. Discovering structural correlations in alpha-helices. Protein Sci. 3 (1994) 1847-1857
20. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., and Steitz T.A. Crystal-structure at 3.5 Angstrom resolution of Hiv-1 reverse-transcriptase complexed with an inhibitor. Science 256 (1992) 1783-1790
21. London R.E., Wingad B.D., and Mueller G.A. Dependence of amino acid side chain 13C shifts on dihedral angle: application to conformational analysis. J. Am. Chem. Soc. 130 (2008) 11097-11105
22. Maier G., Dietrich U., Panhans B., Schroder B., Rubsamen-Waigmann H., Cellai L., Hermann T., and Heumann H. Mixed reconstitution of mutated subunits of HIV-1 reverse transcriptase coexpressed in Escherichia coli-two tags tie it up. Eur. J. Biochem. 261 (1999) 10-18
23. Ming D., and Bruschweiler R. Prediction of methyl-side chain dynamics in proteins. J. Biomol. NMR 29 (2004) 363-368
24. Muchmore D.C., Mcintosh L.P., Russell C.B., Anderson D.E., and Dahlquist F.W. Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Methods Enzymol. 177 (1989) 44-73
25. Neal S., Nip A.M., Zhang H., and Wishart D.S. Rapid and accurate calculation of protein 1H, 13C and 15N chemical shifts. J. Biomol. NMR 26 (2003) 215-240
26. Painter G.R., Aulabaugh A.E., and Andrews C.W. A comparison of the conformations of the 5'-triphosphates of zidovudine (AZT) and thymidine bound to HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun. 191 (1993) 1166-1171
27. Pitcher III W.H., DeRose E.F., Mueller G.A., Howell E.E., and London R.E. NMR studies of the interaction of a type II dihydrofolate reductase with pyridine nucleotides reveal unexpected phosphatase and reductase activity. Biochemistry 42 (2003) 11150-11160
28. Powell M.D., Ghosh M., Jacques P.S., Howard K.J., Le Grice S.F., and Levin J.G. Alanine-scanning mutations in the "primer grip" of p66 HIV-1 reverse transcriptase result in selective loss of RNA priming activity. J. Biol. Chem. 272 (1997) 13262-13269
29. Ren J., Esnouf R., Garman E., Somers D., Ross C., Kirby I., Keeling J., Darby G., Jones Y., Stuart D., et al. High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat. Struct. Biol. 2 (1995) 293-302
30. Ren J., Nichols C., Bird L., Chamberlain P., Weaver K., Short S., Stuart D.I., and Stammers D.K. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J. Mol. Biol. 312 (2001) 795-805
31. Rittinger K., Divita G., and Goody R.S. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8046-8049
32. Rodgers D.W., Gamblin S.J., Harris B.A., Ray S., Culp J.S., Hellmig B., Woolf D.J., Debouck C., and Harrison S.C. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1222-1226
33. Sarafianos S.G., Das K., Tantillo C., Clark Jr. A.D., Ding J., Whitcomb J.M., Boyer P.L., Hughes S.H., and Arnold E. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20 (2001) 1449-1461
34. Shen L., Shen J., Luo X., Cheng F., Xu Y., Chen K., Arnold E., Ding J., and Jiang H. Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT. Biophys. J. 84 (2003) 3547-3563
35. Spence R.A., Kati W.M., Anderson K.S., and Johnson K.A. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science 267 (1995) 988-993
36. Stapley B.J., Rohl C.A., and Doig A.J. Addition of side chain interactions to modified Lifson-Roig helix-coil theory: application to energetics of phenylalanine-methionine interactions. Protein Sci. 4 (1995) 2383-2391
37. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41 (2005) 207-234
38. Sweeney Z.K., Harris S.F., Arora S.F., Javanbakht H., Li Y., Fretland J., Davidson J.P., Billedeau J.R., Gleason S.K., Hirschfeld D., Kennedy-Smith J.J., Mirzadegan T., Roetz R., Smith M., Sperry S., Suh J.M., Wu J., Tsing S., Villasenor A.G., Paul A., Su G., Heilek G., Hang J.Q., Zhou A.S., Jernelius J.A., Zhang F.J., and Klumpp K. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase. J. Med. Chem. 51 (2008) 7449-7458
39. Tachedjian G., and Goff S.P. The effect of NNRTIs on HIV reverse transcriptase dimerization. Curr. Opin. Investig. Drugs 4 (2003) 966-973
40. Tachedjian G., Orlova M., Sarafianos S.G., Arnold E., and Goff S.P. Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7188-7193
41. Thimmig R.L., and McHenry C.S. Human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268 (1993) 16528-16536
42. Tugarinov V., Hwang P.M., Ollerenshaw J.E., and Kay L.E. Cross-correlated relaxation enhanced 1H[bond]13C NMR spectroscopy of methyl groups in very high molecular weight proteins and protein complexes. J. Am. Chem. Soc. 125 (2003) 10420-10428
43. Unge T., Knight S., Bhikhabhai R., Lovgren S., Dauter Z., Wilson K., and Strandberg B. 2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). Structure 2 (1994) 953-961
44. Venezia C.F., Howard K.J., Ignatov M.E., Holladay L.A., and Barkley M.D. Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase. Biochemistry 45 (2006) 2779-2789
45. Wang J., Smerdon S.J., Jager J., Kohlstaedt L.A., Rice P.A., Friedman J.M., and Steitz T.A. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7242-7246
46. Willard L., Ranjan A., Zhang H., Monzavi H., Boyko R.F., Sykes B.D., and Wishart D.S. VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res. 31 (2003) 3316-3319